Últimas noticias sobre IO Biotech (NASDAQ:IOBT) Bolsa

IO Biotech

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

IO Biotech Inc

Wedbush analyst Seth Basham reiterates Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) with a Outperform and maintains $39 price target.

News

Price Target

Reiteration

Analyst Ratings

CHWY

Wedbush Reiterates Outperform on Chewy, Maintains $39 Price Target

Trading Ideas

GLMD

Galmed Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 67.9%

<a href="https://corp.roblox.com/newsroom/2025/03/unveiling-future-creation-native-3d-generation-collaborative-studio-tools-economy-expansion">https://corp.roblox.com/newsroom/2025/03/unveiling-future-creation-native-3d-generation-collaborative-studio-tools-economy-expansion</a>
&nbsp;

RBLX

'Unveiling The Future Of Creation With Native 3D Generation, Collaborative Studio Tools, And Economy Expansion' - Roblox

Contracts

New Fortress Energy Amends Extension Of Islandwide Gas Supply Contract With Puerto Rico Electric Power Authority To 100 Days Term

Wedbush analyst Jay McCanless reiterates Lennar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) with a Neutral and maintains $158 price target.

Wedbush Reiterates Neutral on Lennar, Maintains $158 Price Target

In the current market session, Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) share price is at $101.63, after a 0.83% increase. Moreover, over the past month, the stock decreased by 4.70%, but in the past year, increased by 8.26%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1742218217_0.png" alt="Past Year Chart" />

<h3>Micron Technology P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 139.9 in the Semiconductors &amp; Semiconductor Equipment industry, Micron Technology Inc. has a lower P/E ratio of 28.88. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1742218217_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

Price Over Earnings Overview: Micron Technology

Shares of clothing company Guess?, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) are <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">trading higher in premarket</a> on Monday.
The company has announced that its <a href="https://www.benzinga.com/pressreleases/25/03/b44354678/guess-inc-receives-going-private-proposal-from-whp-global" target="_blank" rel="noreferrer noopener">Board of Directors has received </a>a non-binding proposal from WHP Global, through its affiliate WHP Investments, LLC, for the acquisition of all outstanding shares of Guess? at a price of $13.00 per share in cash.
The offer represents a premium of 34% to the last closing price of $9.70.
The proposal excludes shares held by certain existing shareholders, including Paul Marciano, Maurice Marciano, and Carlos Alberini.
The company has created a Special Committee of independent directors to assess the proposal with the help of financial and legal advisors.
The deal is expected to be financed with a combination of equity, third-party debt financing, and rollover or reinvestment by the Proposed Rollover Shareholders.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/03/44352234/astrazeneca-seals-deal-for-esobiotec-to-advance-cell-therapy-details" rel="noreferrer noopener">AstraZeneca Seals Deal For EsoBiotec To Advance Cell Therapy: Details</a>
The proposal assumes that Guess? will continue its operations as usual, with no significant changes to its strategic or operational position.
The Special Committee&#8217;s review aims to determine the best course of action for the company and its shareholders.
Guess? has indicated that it will provide further updates once the Special Committee has concluded its evaluation.
Back in April 2024, Guess? had entered into a partnership with WHP to acquire the intellectual property and operational assets of the New York-based fashion brand rag &amp; bone.
Guess? now directly operates rag &amp; bone stores in the U.S. and the U.K., as well as offering the brand through high-end boutiques, department stores, and global e-commerce platforms.
Price Action: GES shares traded higher by 25.4% at $12.15 in premarket at last check Monday.
Image via Shutterstock.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44330842/why-is-visionary-holdings-stock-surging-today" target="_blank" rel="noreferrer noopener">Visionary Holdings Fast-Tracks Battery Swap Expansion As Loan Process Underway</a></li>
</ul>

Equities

Movers

General

Why Is Clothing Firm Guess Stock Surging Today?

Crypto
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44354418/bitcoin-holds-steady-at-84000-as-wednesday-fomc-meeting-looms" target="_blank" rel="noreferrer noopener">Bitcoin Holds Steady At $84,000 As Wednesday FOMC Meeting Looms</a></li>
<li><a href="https://www.benzinga.com/25/03/44353212/can-bitcoins-ibit-surpass-spy-to-become-the-largest-etf-we-asked-ai-bots-perplexity-and-grok-this-question-and-heres-how-they-responded" target="_blank" rel="noreferrer noopener">Can Bitcoin&#8217;s IBIT Surpass SPY To Become The Largest ETF? We Asked AI Bots Perplexity And Grok This Question, And Here&#8217;s What They Said</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44351763/bitcoin-technologist-opposes-quantum-recovery-of-lost-btc-advocates-for-coin-burning" target="_blank" rel="noreferrer noopener">Bitcoin Technologist Opposes Quantum Recovery Of Lost BTC, Advocates Coin Burning</a></li>
<li><a href="https://www.benzinga.com/25/03/44351390/strategys-unrealized-gains-hit-hard-following-bitcoins-price-slump" target="_blank" rel="noreferrer noopener">Strategy&#8217;s Unrealized Gains Hit Hard Following Bitcoin&#8217;s Price Slump</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44349867/bitcoin-dogecoin-were-muffled-last-week-but-telegrams-pavel-durov-getting-his-passport-back-gave-toncoin-its-wings" target="_blank" rel="noreferrer noopener">Bitcoin, Dogecoin Were Muffled Last Week But Telegram&#8217;s Pavel Durov Getting His Passport Back Gave Toncoin Its Wings</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44349644/kim-jong-uns-north-korea-backed-lazarus-group-now-has-more-bitcoin-than-el-salvador" target="_blank" rel="noreferrer noopener">Kim Jong Un&#8217;s North Korea-Backed Lazarus Group Now Has More Bitcoin Than El Salvador</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/03/44349487/melania-surges-6-after-whale-with-40x-short-bet-on-bitcoin-goes-long-on-first-ladys-memecoin" target="_blank" rel="noreferrer noopener">MELANIA Surges 6% After Whale With 40x Short Bet On Bitcoin Goes Long On First Lady&#8217;s Memecoin</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/03/44349475/shiba-inu-defies-memecoin-dump-with-with-a-5-spike-analyst-says-500-upside-could-still-be-well-in-the-works" target="_blank" rel="noreferrer noopener">Shiba Inu Defies Memecoin Dump With With A 5% Spike — Analyst Says 500% Upside &#8216;Could Still Be Well In The Works&#8217;</a></li>
<li><a href="https://www.benzinga.com/25/03/44349226/bitcoin-ethereum-dogecoin-slid-ahead-of-feds-interest-rate-decision-analyst-predicts-8-btc-upside-if-it-breaks-through-this-pattern" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Slide Ahead Of Fed&#8217;s Interest Rate Decision: Next Week To Be &#8216;Strong &amp; Green&#8217; If Altcoins Don&#8217;t Get Dumped On Monday, Says Trader</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44348233/unprecedented-400-surge-in-dogecoin-network-activity-a-bullish-move" target="_blank" rel="noreferrer noopener">Unprecedented 400% Surge in Dogecoin Network Activity: A Bullish Move?</a></li>
</ul>
US Markets­­­­­­­­
<ul>
<li><a href="https://www.benzinga.com/25/03/44351741/us-stocks-likely-to-open-lower-as-futures-decline-stay-calm-and-stick-with-your-long-term-plan-says-expert-amid-correction-woes" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Lower As Futures Decline: &#8216;Stay Calm And Stick With Your Long-Term Plan,&#8217; Says Expert Amid Correction Woes</a></li>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44350934/sp-500-price-trend-flashes-warning-signals-but-this-expert-says-start-looking-for-a-buy-signal-after-last-weeks-drawdown" target="_blank" rel="noreferrer noopener">S&amp;P 500 Price Trend Flashes Warning Signals But This Expert Says &#8216;Start Looking For A Buy Signal&#8217; After Last Week&#8217;s Drawdown</a></li>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44350012/sp-jumps-over-2-but-records-weekly-loss-investor-fear-eases-but-fear-greed-index-remains-in-extreme-fear-zone" target="_blank" rel="noreferrer noopener">S&amp;P Jumps Over 2%, But Records Weekly Loss: Investor Fear Eases, Greed Index Remains In &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>
US Politics
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/03/44353947/trumps-cfpb-overhaul-leaves-consumers-exposed-heres-what-it-means-for-your-money" target="_blank" rel="noreferrer noopener">Trump&#8217;s CFPB Overhaul Leaves Consumers Exposed—Here&#8217;s What It Means For Your Money</a></li>
<li><a href="https://www.benzinga.com/markets/25/03/44352317/mark-cuban-slams-trump-administration-for-inflicting-economic-struggles-on-a-majority-of-republican-supporters-this-could-flip-voters" target="_blank" rel="noreferrer noopener">Mark Cuban Slams Trump Administration For Inflicting Economic Struggles On A Majority Of Republican Supporters: &#8216;This Could Flip Voters&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/25/03/44348205/scaramucci-sees-trouble-ahead-for-musk-trump-relationship-everyone-flames-out-with-trump" target="_blank" rel="noreferrer noopener">Scaramucci Sees Trouble Ahead for Musk-Trump Relationship: &#8216;Everyone Flames Out With Trump&#8217;</a></li>
</ul>
World Politics
<ul>
<li><a href="https://www.benzinga.com/media/25/03/44349466/trump-trade-policy-a-big-headache-for-customers-says-apple-supplier-foxconns-ceo-very-very-hard-to-predict-how-things-will-develop" target="_blank" rel="noreferrer noopener">Trump Trade Policy A &#8216;Big Headache&#8217; For Customers, Says Apple-Supplier Foxconn&#8217;s CEO: &#8216;Very, Very Hard To Predict How Things Will Develop&#8230;&#8217;</a></li>
<li><a href="https://www.benzinga.com/25/03/44348859/trump-says-he-was-little-bit-sarcastic-when-he-said-he-would-end-the-russia-ukraine-war-in-a-day-what-i-really-mean-is" target="_blank" rel="noreferrer noopener">Trump Says He Was &#8216;Little Bit Sarcastic&#8217; When He Said He Would End The Russia-Ukraine War In A Day: &#8216;What I Really Mean Is&#8230;&#8217;</a></li>
</ul>
US Economy
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44349451/third-largest-buy-the-dip-in-history-bofas-sees-correction-not-a-bear-market-amid-wall-street-rebound" target="_blank" rel="noreferrer noopener">Third-Largest &#8216;Buy-The-Dip&#8217; In History — BofA&#8217;s Sees &#8216;Correction, Not A Bear Market&#8217; Amid Wall Street Rebound</a></li>
<li><a href="https://www.benzinga.com/news/25/03/44348262/trump-musk-and-democrats-get-low-marks-on-economy-in-nbc-poll" target="_blank" rel="noreferrer noopener">Trump, Musk, and Democrats Get Low Marks on Economy in NBC Poll</a></li>
</ul>
World Economy
<ul>
<li><a href="https://www.benzinga.com/25/03/44353578/safe-haven-amidst-volatility-gold-tops-3000-as-market-corrects-but-it-tends-to-see-painful-drawdowns-after-periods-of-sharp-gains-says-expert" target="_blank" rel="noreferrer noopener">Safe Haven Amidst Volatility? Gold Tops $3000 As Market Corrects But It Tends To See &#8216;Painful Drawdowns After Periods Of Sharp Gains,&#8217; Says Expert</a></li>
<li><a href="https://www.benzinga.com/25/03/44353286/asia-and-europe-markets-rise-oil-gains-on-geopolitical-tensions-gold-holds-above-3000-global-markets-today-while-us-slept" target="_blank" rel="noreferrer noopener">Asia And Europe Markets Rise, Gold Holds Above $3,000 &#8211; Global Markets Today While US Slept</a></li>
</ul>
Tech
<ul>
<li><a href="https://www.benzinga.com/25/03/44353699/niu-q4-rides-high-on-demand-for-e-scooters-but-gross-margins-decline-amid-higher-costs" target="_blank" rel="noreferrer noopener">Niu Q4 Rides High On Demand For E-Scooters, But Gross Margins Decline Amid Higher Costs</a></li>
<li><a href="https://www.benzinga.com/25/03/44352695/ff-open-ai-day-faraday-future-launches-aiher-aims-to-revolutionize-ev-and-hybrid-powertrains" target="_blank" rel="noreferrer noopener">FF Open AI Day: Faraday Future Launches AIHER, Aims To Revolutionize EV And Hybrid Powertrains</a></li>
<li><a href="https://www.benzinga.com/tech/25/03/44352209/gtc-2025-could-reignite-nvidias-stock-rally-but-only-if-b300-ai-server-roadmap-and-scaling-concerns-are-addressed-says-top-analyst" target="_blank" rel="noreferrer noopener">GTC 2025 Could Reignite Nvidia&#8217;s Stock Rally, But Only If B300, AI Server Roadmap, And Scaling Concerns Are Addressed, Says Top Analyst</a></li>
<li><a href="https://www.benzinga.com/media/25/03/44351682/meta-whistleblower-reveals-how-a-low-ranking-indian-official-outsmarted-mark-zuckerberg-and-crushed-facebooks-free-basics-with-one-single-click" target="_blank" rel="noreferrer noopener">Meta Whistleblower Reveals How A &#8216;Low-Ranking&#8217; Indian Official Outsmarted Mark Zuckerberg And Crushed Facebook&#8217;s Free Basics With One Single Click</a></li>
<li><a href="https://www.benzinga.com/25/03/44351448/top-wall-street-forecasters-revamp-getty-images-price-expectations-ahead-of-q4-earnings" target="_blank" rel="noreferrer noopener">Top Wall Street Forecasters Revamp Getty Images Price Expectations Ahead Of Q4 Earnings</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44350873/nvidia-faces-new-ai-challenge-as-chinese-start-up-unveils-framework-to-cut-reliance-on-its-gpus" target="_blank" rel="noreferrer noopener">Nvidia Faces New AI Challenge As Chinese Start-Up Unveils Framework To Cut Reliance On Its GPUs</a></li>
<li><a href="https://www.benzinga.com/25/03/44350823/oracle-reportedly-in-talks-with-white-house-over-project-texas-20-to-manage-tiktok-amid-security-concerns" target="_blank" rel="noreferrer noopener">Oracle In Talks With White House To Oversee US Operations Of TikTok As Part Of Project Texas 2.0: Report</a></li>
<li><a href="http://benzinga.com/media/25/03/44350512/apples-ai-crisis-reaches-boiling-point-ahead-of-top-100-executive-retreat-tim-cook-and-key-execs-called-out-over-siri-failure-by-top-analyst" target="_blank" rel="noreferrer noopener">Apple&#8217;s AI Crisis Reaches Boiling Point Ahead Of Top 100 Executive Retreat — Tim Cook And Key Execs Called Out Over Siri Failure By Top Analyst</a></li>
<li><a href="https://www.benzinga.com/25/03/44349807/amazon-pursued-roomba-parent-once-but-now-the-companys-robot-vacuums-face-heat-from-chinese-rivals" target="_blank" rel="noreferrer noopener">Amazon Pursued Roomba&#8217;s Parent Once, But Now The Company&#8217;s Robot Vacuums Face Heat From Chinese Rivals With AI-Powered Arms</a></li>
<li><a href="https://www.benzinga.com/25/03/44349635/baidu-says-its-new-ai-is-smarter-than-deepseeks-and-costs-half-as-much-excellent-multimodal-understanding-ability" target="_blank" rel="noreferrer noopener">Baidu Says Its New AI Is Smarter Than DeepSeek&#8217;s — And Costs Half As Much: &#8216;Excellent Multimodal Understanding Ability</a></li>
</ul>
Electric Vehicle
<ul>
<li><a href="https://www.benzinga.com/25/03/44354592/warren-buffett-backed-byd-eyes-germany-for-third-european-plant-amid-tariff-concerns-report" target="_blank" rel="noreferrer noopener">Warren Buffett-Backed BYD Eyes Germany For Third European Plant Amid Tariff Concerns: Report</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44351076/elon-musk-as-nissans-fix-carlos-ghosn-says-automaker-lacks-vision-decision-clarity-judgment-insight" target="_blank" rel="noreferrer noopener">Elon Musk As Nissan&#8217;s Fix? Carlos Ghosn Says Automaker Lacks &#8216;Vision, Decision, Clarity, Judgment, Insight&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44350195/ross-gerber-shares-peaceful-display-of-distaste-for-elon-musk-in-santa-monica-his-9-year-old-observes-glad-we-dont-have-a-tesla" target="_blank" rel="noreferrer noopener">Ross Gerber Shares &#8216;Peaceful Display Of Distaste For Elon Musk&#8217; In Santa Monica, His 9-Year Old Observes, &#8216;Glad We Don&#8217;t Have A Tesla&#8217;</a></li>
<li><a href="http://benzinga.com/markets/equities/25/03/44349240/googles-waymo-leads-robotaxi-race-with-2-millon-paid-rides-zoox-challenges-tesla-for-second-spot-as-unsupervised-autonomy-becomes-table-stakes-says-gary-black" target="_blank" rel="noreferrer noopener">Google&#8217;s Waymo Leads Robotaxi Race With 2 Millon Paid Rides, Amazon&#8217;s Zoox Challenges Tesla For Second Spot As Autonomy Becomes &#8216;Table Stakes,&#8217; Says Gary Black</a></li>
</ul>
Industrial
<ul>
<li><a href="https://www.benzinga.com/25/03/44354456/cbak-energy-posts-1179m-profit-in-fy24-ceo-highlights-resilience-in-battery-market" target="_blank" rel="noreferrer noopener">CBAK Energy Posts Profit in FY24, CEO Highlights Resilience In Battery Market</a></li>
</ul>
Healthcare
<ul>
<li><a href="https://www.benzinga.com/25/03/44353774/eventful-monday-for-astrazeneca-aces-phase-3-hypoparathyroidism-trial-inks-technology-pact-european-approval-for-imfinzi-for-lung-cancer" target="_blank" rel="noreferrer noopener">Eventful Monday For AstraZeneca &#8211; What&#8217;s Going On?</a></li>
<li><a href="https://www.benzinga.com/general/health-care/25/03/44352653/exclusive-fda-approves-monogram-technologies-mbos-tka-system-for-knee-surgery" target="_blank" rel="noreferrer noopener">FDA Approves Monogram Technologies&#8217; mBôs TKA System For Knee Surgery</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44352234/astrazeneca-seals-deal-for-esobiotec-to-advance-cell-therapy-details" target="_blank" rel="noreferrer noopener">AstraZeneca Seals Deal For EsoBiotec To Advance Cell Therapy: Details</a></li>
</ul>
Financial
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44353719/warren-buffets-berkshire-hathaway-boosts-stake-in-japans-top-trading-firms" target="_blank" rel="noreferrer noopener">Warren Buffet&#8217;s Berkshire Hathaway Boosts Stake In Japan&#8217;s Top Trading Firms</a></li>
<li><a href="https://www.benzinga.com/25/03/44350479/warren-buffett-plans-to-sell-his-real-estate-brokerage-but-its-not-a-bet-against-us-home-prices-says-analyst-as-fed-expects-to-keep-rates-unchanged" target="_blank" rel="noreferrer noopener">Warren Buffett Plans To Sell His Real Estate Brokerage, But It&#8217;s &#8216;Not… A Bet Against US Home Prices,&#8217; Says Analyst As Fed Expects To Keep Rates Unchanged</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44349818/warren-buffett-dumped-nearly-70-of-apple-shares-but-its-price-to-sales-ratio-remains-elevated-at-8-2x-warns-this-market-analyst" target="_blank" rel="noreferrer noopener">Warren Buffett Dumped Nearly 70% Of Apple Shares, But Its Price-To-Sales Ratio Remains Elevated At 8.2x, Warns This Market Analyst</a></li>
</ul>
Space
<ul>
<li><a href="https://www.benzinga.com/25/03/44350440/elon-musk-confirms-starship-to-carry-tesla-optimus-to-mars-by-2026-predicts-human-landing-by-2029" target="_blank" rel="noreferrer noopener">Elon Musk Confirms Starship To Carry Tesla Optimus To Mars by 2026, Predicts Human Landing By 2029</a></li>
<li><a href="https://www.benzinga.com/25/03/44349255/rocket-lab-launches-lightning-god-reigns-mission-for-japans-iqps-sets-sights-on-high-five-launch-just-three-days-later" target="_blank" rel="noreferrer noopener">Rocket Lab Launches &#8216;Lightning God Reigns&#8217; Mission, Sets Sights On &#8216;High Five&#8217; Launch Just Three Days Later</a></li>
</ul>
Image via Shutterstock

$BTC

$ETH

Nvidia Confronts Fresh AI Rival From China; Bitcoin Steady At $84K Ahead Of FOMC; AstraZeneca Acquires EsoBiotec For Cell Therapy Push – Top Headlines While The U.S. Slept

WIIM

AVGO

Broadcom shares are trading lower following a report from The Information suggesting Google tapped MediaTek for cheaper AI chips.

In a move to replace U.S. components in its PC business, Chinese tech giant Huawei Technologies has made significant progress in creating its in-house computer chips
What Happened: Huawei&#8217;s chip design subsidiary, HiSilicon, has developed the Kirin X90 chip, which recently received a Level 2 national certification for security and reliability from the government-supported China Information Technology Security Evaluation Centre.
This voluntary certification enables companies to evaluate the security standards of their locally designed and manufactured computers, server CPUs, and systems, often acting as a gateway to adoption.
The company's in-house Kirin 9000C and Kirin 9006C chips, utilized in the Qingyun W515x personal computer and Qingyun L540 laptop, respectively, have already obtained certifications. The Qingyun computer series is tailored for government and enterprise users.
Huawei&#8217;s license to use Microsoft Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Windows operating system is set to expire this month without renewal. According to a report from the Chinese news outlet Thepaper.cn, the company plans to launch PCs equipped with its own HarmonyOS system later this year.
SEE ALSO: <a href="https://www.benzinga.com/25/03/44354592/warren-buffett-backed-byd-eyes-germany-for-third-european-plant-amid-tariff-concerns-report">Warren Buffett-Backed BYD Eyes Germany For Third European Plant Amid Tariff Concerns: Report</a>
Why It Matters: This development comes as Huawei seeks to replace U.S. components in its PC business amid ongoing U.S. sanctions. In May, Washington rescinded special licenses that had permitted chip suppliers Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) and Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) to sell older-generation semiconductors to Huawei which was used in its laptops and smartphones.
Furthermore, there are growing concerns in China about the escalating trade tensions with the US. Chinese President Xi Jinping has expressed fears that these <a href="https://www.benzinga.com/25/03/44161587/is-china-apprehensive-of-losing-the-trade-war-to-the-us-china-could-get-isolated-like-moscow-fears-xi-jinping">tensions might lead</a> to China&#8217;s isolation, similar to the Soviet Union&#8217;s during the Cold War.
Huawei&#8217;s development of its own computer chips and operating system is a significant move in this ongoing tech war, demonstrating the company&#8217;s efforts to reduce its reliance on American technology amid increasing sanctions and trade tensions.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/25/03/44355124/intels-new-ceo-charts-bold-revival-plan-warns-of-tough-decisions-ahead-reports">Intel&#8217;s New CEO Charts Revival Plan, Warns Of &#8216;Tough Decisions&#8217; Ahead: Report</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Global

Tech

INTC

MSFT

QCOM

Huawei Develops In-House Chips To Counter US Sanctions, Leap Ahead In The Tech War

--Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease--
--Data Presented at the 2025 Muscular Dystrophy Association (MDA) Conference--

Biotech

CAPR

Capricor Therapeutics Announces Data From Ongoing HOPE-2 Open Label Extension Clinical Trial

V2X (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVX#NYSE">VVX</a>) has been awarded a position on the U.S. Navy's Worldwide Expeditionary Multiple Award Contract (WEXMAC) 2.0, a key vehicle for delivering enhanced global logistics capabilities.
Administered jointly by the Army Contracting Command and the Naval Supply Systems Command, WEXMAC 2.0 streamlines procurement processes and integrates technology to enhance logistical support for joint forces and federal agencies worldwide. The contract is designed to strengthen global military operations through rapid and efficient supply chain solutions.
V2X was selected to support 22 regions and will leverage its global footprint to deliver solutions and logistical capabilities that sustain and set the theater. This multiple-award, indefinite-delivery/indefinite-quantity contract has an initial five-year period with a ceiling value of $1.2 billion, with an option to extend up to 10 years for a total of $2.4 billion.

V2X Selected for Navy's WEXMAC 2.0 Contract; V2X Was Selected To Support 22 Regions, This Multiple-Award, Indefinite-Delivery/Indefinite-Quantity Contract Has An Initial 5-Year Period With A Ceiling Value Of $1.2B, With An Option To Extend Up To 10 Years For A Total Of $2.4B

Wedbush analyst Richard Anderson reiterates National Health Investors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NHI#NYSE">NHI</a>) with a Outperform and maintains $88 price target.

Wedbush Reiterates Outperform on National Health Investors, Maintains $88 Price Target

<ul>
<li>TSLA</li>
<li>NVDA</li>
<li>QBTS</li>
<li>AAPL</li>
<li>$BTC</li>
<li>WAR</li>
<li>CORN</li>
<li>MSTR</li>
<li>INTC</li>
<li>GLD</li>
</ul>
Data From <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

CORN

MSTR

NVDA

QBTS

TSLA

Top 10 Trending Stocks On WallStreetBets As Of March 17, 2025 (Via Swaggy Stocks)

Keybanc analyst Ken Newman maintains WESCO Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCC#NYSE">WCC</a>) with a Overweight and lowers the price target from $245 to $205.

Keybanc Maintains Overweight on WESCO Intl, Lowers Price Target to $205

Open Lending Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPRO#NASDAQ">LPRO</a>) will release its fourth-quarter financial results after the <a href="https://www.benzinga.com/quote/lpro/earnings">closing bell on Monday, March 17.</a>
Analysts expect the Austin, Texas-based company to report quarterly earnings at 2 cents per share, versus a year-ago loss of 4 cents per share. Open Lending projects quarterly revenue of $24.02 million, compared to $14.94 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Nov. 7, 2024, Open Lending posted downbeat third-quarter results.
Open Lending shares gained 1.2% to close at $4.31 on Friday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/LPRO/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Needham analyst Mayank Tandon reiterated a Hold rating on Oct. 2, 2024. This analyst has an accuracy rate of 69%.</li>
<li>DA Davidson analyst Peter Heckmann maintained a Buy rating and cut the price target from $9 to $8 on Aug. 12, 2024. This analyst has an accuracy rate of 75%.</li>
<li>JMP Securities analyst David Scharf maintained a Market Outperform rating and cut the price target from $8 to $7 on Aug. 9, 2024. This analyst has an accuracy rate of 67%.</li>
<li>Morgan Stanley analyst James Faucette maintained an Equal-Weight rating and slashed the price target from $6 to $5 on Aug. 9, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Canaccord Genuity analyst Joseph Vafi maintained a Hold rating and lowered the price target from $7 to $6 on May 8, 2024. This analyst has an accuracy rate of 69%.</li>
</ul>
Considering buying LPRO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="585" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16044923/image-131-1024x585.png" alt="" class="wp-image-826060" style="width:605px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16044923/image-131-1024x585.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16044923/image-131-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16044923/image-131-768x439.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16044923/image-131.png 1088w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44326690/top-3-materials-stocks-that-may-collapse-in-march">Top 3 Materials Stocks That May Collapse In March</a></li>
</ul>

Earnings

Pre-Market Outlook

LPRO

Open Lending Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Keybanc analyst Ken Newman maintains Applied Industrial Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) with a Overweight and lowers the price target from $325 to $275.

Keybanc Maintains Overweight on Applied Industrial Techs, Lowers Price Target to $275

Wells Fargo analyst Michael Blum upgrades Genesis Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEL#NYSE">GEL</a>) from Equal-Weight to Overweight and raises the price target from $15 to $18.

Upgrades

Wells Fargo Upgrades Genesis Energy to Overweight, Raises Price Target to $18

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Hewlett Packard Enterprise Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>)</h3>
<ul>
<li>On March 6, Hewlett Packard issued second-quarter guidance below estimates. "HPE achieved our fourth consecutive quarter of year-over-year revenue growth, increasing revenue by double digits in Q1," said Antonio Neri, CEO of Hewlett Packard Enterprise. The company's stock fell around 28% over the past month and has a <a href="https://www.benzinga.com/quote/HPE">52-week low of $14.64</a>.</li>
<li>RSI Value: 25.6</li>
<li>HPE Price Action: Shares of Hewlett Packard Enterprise gained 5.8% to close at $15.62 on Friday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest HPE <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="921" height="857" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134303/image-132.png" alt="" class="wp-image-826138" style="width:502px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134303/image-132.png 921w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134303/image-132-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134303/image-132-768x715.png 768w" sizes="(max-width: 921px) 100vw, 921px" /></a></figure>
<h3 class="wp-block-heading">BILL Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>)</h3>
<ul>
<li>On Feb. 6, the company issued third-quarter total revenue guidance below estimates. "We delivered strong financial results and innovated at a rapid pace as we executed on our vision to be the de facto intelligent financial operations platform for SMBs," said René Lacerte, founder and CEO of Bill Holdings. The company's stock fell around 23% over the past month and <a href="https://www.benzinga.com/quote/BILL">has a 52-week low</a> of $42.82.</li>
<li>RSI Value: 29.1</li>
<li>BILL Price Action: Shares of BILL Holdings gained 5.4% to close at $46.42 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">BILL stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="846" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134403/image-133.png" alt="" class="wp-image-826139" style="width:538px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134403/image-133.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134403/image-133-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134403/image-133-768x712.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">Five9 Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>)</h3>
<ul>
<li>On Feb. 20, Five9 reported better-than-expected fourth-quarter financial results. "We are very pleased to report strong year end results, with 2024 annual revenue exceeding $1 billion. Fourth quarter revenue growth accelerated to 17%, driven by our subscription revenue growing 19%. We reached an all-time record adjusted EBITDA margin of 23%, helping drive our highest ever quarterly operating cash flow of $50 million," said Mike Burkland, Five9 CEO. The company's stock fell around 31% over the past month and has a 52-week<a href="https://www.benzinga.com/quote/FIVN"> low of $26.60.</a></li>
<li>RSI Value: 26.9</li>
<li>FIVN Price Action: Shares of Five9 gained 4.4% to close at $29.47 on Friday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">FIVN shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="882" height="856" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134519/image-134.png" alt="" class="wp-image-826140" style="width:576px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134519/image-134.png 882w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134519/image-134-300x291.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16134519/image-134-768x745.png 768w" sizes="(max-width: 882px) 100vw, 882px" /></a></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/03/44326690/top-3-materials-stocks-that-may-collapse-in-march">Top 3 Materials Stocks That May Collapse In March</a></li>
</ul>

Long Ideas

BILL

FIVN

Top 3 Tech Stocks That Are Preparing To Pump This Quarter

Events

TNFA

TNF Pharmaceuticals Presents Novel Oral TNF-Alpha Inhibitor At Premier International Conference On Frailty And Sarcopenia

Health Care

Press Releases

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting

IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study

IO Biotech Announces Participation in Upcoming Investor Conferences

IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Financing

IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank

IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer

IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate

IO Biotech to Present at the 45th Annual Cowen Health Care Conference

IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference

Comments

IO Biotech

Noticias

Últimas noticias sobre IO Biotech (NASDAQ:IOBT) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL